about
Making the Leap from Research Laboratory to Clinic: Challenges and Opportunities for Next-Generation Sequencing in Infectious Disease DiagnosticsTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsNext-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneityTranslating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps--an open letter to world leadersThe diagnostic approach to monogenic very early onset inflammatory bowel diseaseBioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trialUse of contemporary genetics in cardiovascular diagnosisDeveloping context-specific next-generation sequencing policyA clinical research integration special program (CRISP) for young women with primary ovarian insufficiencyPlatform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral DecompositionClinical integration of next generation sequencing: coverage and reimbursement challenges.Democratization of genetic data: connecting government approval of clinical tests with data sharing.Mining of public sequencing databases supports a non-dietary origin for putative foreign miRNAs: underestimated effects of contamination in NGS.Companion diagnostics for targeted cancer drugs - clinical and regulatory aspectsProgress in genomics according to bingo: 2013 edition.A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samplesAdvantages of genome sequencing by long-read sequencer using SMRT technology in medical area.A web tool for the design and management of panels of genes for targeted enrichment and massive sequencing for clinical applications.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.High-Throughput Sequencing, a VersatileWeapon to Support Genome-Based Diagnosis in Infectious Diseases: Applications to Clinical BacteriologyLeveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing.The unintended implications of blurring the line between research and clinical care in a genomic age.Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area.From Phenotype to Genotype: Enter Genomics and Transformation of Primary Health Care around the WorldTumor genome analysis includes germline genome: are we ready for surprises?Clinical outcome of preimplantation genetic diagnosis and screening using next generation sequencing.XomAnnotate: Analysis of Heterogeneous and Complex Exome- A Step towards Translational Medicine.The road from next-generation sequencing to personalized medicine.Confidentiality and data sharing: vulnerabilities of the Mexican Genomics Sovereignty ActUse of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics Clinic.Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies.Scalable and cost-effective NGS genotyping in the cloud.Exome sequencing for molecular characterization of non-HFE hereditary hemochromatosis.Use of semantic workflows to enhance transparency and reproducibility in clinical omics.The Role of Quality Control in Targeted Next-generation Sequencing Library Preparation.FDA's Proposed Guidance for Laboratory Developed Tests: How Should Regulators Balance the Risks and Promise of Innovation in Clinical Genetics?Identification of Two Cases of Ciliopathy-Associated Diabetes and Their Mutation Analysis Using Whole Exome SequencingToward clinical genomics in everyday medicine: perspectives and recommendations
P2860
Q26773525-4A060DBE-D57A-4439-B989-280136F8D568Q26776394-FEA027E9-71B6-4351-A0E5-C728C44A34C0Q26992272-E8110B92-0018-406C-A06C-602C50B610B2Q27003942-AB105280-8BF7-4DB1-8C94-F6DAF2345E9BQ27015077-6FB4D4A8-7B1E-4D44-B700-7A02CF1CA7C8Q27015838-2F69CD34-4D9C-47A4-BCD9-C6FFB8D329A6Q27025306-9A06C14E-C73B-4905-BE9F-6557D933BDE9Q28595477-C70C1946-E190-41B0-B322-A4843828B2E3Q28972322-5ACA5F94-B7D5-426F-9632-D859699939C7Q29300552-57C59E2D-8937-41C6-81B7-788D3E8DF465Q30355277-164B38FB-6F41-4EC6-A1D9-589257B88B5DQ31091036-4100DC79-D31A-415D-9877-A4396F7FF583Q33626205-0E9A2603-527F-4B05-A7C7-3AD98679BBACQ33657876-E49ED6F0-A656-4DFF-A466-FF7EB5A8849DQ33745527-53245509-FC37-4255-B5A2-F3185DD458D0Q33839439-3928A2E9-AA29-4A73-B06C-785ECF35BE44Q33841607-75E8821B-20DA-4C6C-AA8E-8F17DCBCF021Q33860873-3D9FC8A6-4AEC-4ACC-9584-57CE1F5E27B5Q34404209-BBC96581-191D-4D68-9F4A-F00F8D91C954Q34521706-41BC0C8A-4E62-40CA-961B-4787E0F2D15DQ34569184-80B35F8D-70F6-482A-92E1-FB28355A6F0EQ34606998-A5E75115-3024-41F4-B948-9053691C6A95Q34675532-4610040E-2D86-4BCB-9528-9365170C1611Q34879739-72BCB294-0014-49F2-8B2D-B3BB49EA2C1CQ34949731-7FC98CBD-46D6-4FE8-B179-62127085F96FQ35004182-09FC426E-4AF8-4459-B641-E2D88E11AE9BQ35079130-FA7C4F57-AE2F-46FB-BA6C-934C63A7F922Q35533034-0AABBE83-EF2E-4D07-8935-FFE745193924Q35623147-355F22C1-1055-4A4F-B718-6E6272E65AD3Q35635455-1F109911-D315-4009-9661-61DDF5C5FAE3Q35648306-570DF458-1A42-443E-B65C-974DC9064D96Q35664233-EC7DAF17-C73A-4508-A005-8387C8B77541Q35766366-9FDFEA58-1D14-4246-963A-F32B02860FD3Q35809152-E2F084D0-27EF-42B1-B17C-233672D6AFD7Q35817450-45C38423-4987-4129-90F7-4BAC0C161C4EQ35985522-E6297692-9CB0-4134-9544-0DC403FF21F6Q36090815-AEA98411-9887-4176-A527-A557367D7C54Q36121843-107AC198-10B4-4F88-8CA2-BC48C7E296D4Q36271997-AB89E4F6-D67B-413C-B2A4-D3D25D891534Q36825747-512B448E-5F83-4F05-BAFF-BEE2F5B936D9
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
First FDA authorization for next-generation sequencer.
@en
First FDA authorization for next-generation sequencer.
@nl
type
label
First FDA authorization for next-generation sequencer.
@en
First FDA authorization for next-generation sequencer.
@nl
prefLabel
First FDA authorization for next-generation sequencer.
@en
First FDA authorization for next-generation sequencer.
@nl
P2860
P356
P1476
First FDA authorization for next-generation sequencer.
@en
P2093
Margaret A Hamburg
P2860
P304
P356
10.1056/NEJMP1314561
P407
P577
2013-11-19T00:00:00Z